End-stage kidney disease and dialysis; pharmacology and pharmacotherapy; epidemiology; comparative safety and effectiveness research
Education and Experience
BS: State University of New York (SUNY) College at Geneseo, 2005
PharmD: Albany College of Pharmacy, 2008
Nephrology Pharmacotherapy Fellow: Albany College of Pharmacy/Albany Medical College, 2009-2012
MS: SUNY University at Albany, 2011
PhD: University of North Carolina, 2017
Post-Doctoral Fellow: University of North Carolina Kidney Center, 2017-2019
Assistant Professor: University of North Carolina, 2019-present
Dr. Assimon’s current research focuses on using administrative claims data and electronic health care record (EHR) data to evaluate the safety and effectiveness of medications commonly used by maintenance dialysis patients. She hopes to translate her medication-related research findings into quality improvement initiatives and policies that promote safe and effective medication prescribing among clinicians who care for dialysis patients.
Outside of her medication-related research, Dr. Assimon is interested in leveraging dialysis unit-based EHR data to identify modifiable aspects of the hemodialysis procedure that can be targeted and optimized to improve patient outcomes.
Assimon MM, Brookhart MA, Flythe JE. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. J Am Soc Nephrol. 2019 Apr;30(4):611-623.
Assimon MM, Brookhart MA, Fine JP, Heiss G, Layton JB, Flythe JE. A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis. Am J Kidney Dis. 2018 Sep;72(3):337-348.
Assimon MM, Wang L, Flythe JE. Failed Target Weight Achievement Associates with Short-Term Hospital Encounters among Individuals Receiving Maintenance Hemodialysis. J Am Soc Nephrol. 2018 Aug;29(8):2178-2188.
Assimon MM, Wang L, Flythe JE. Intradialytic Hypertension Frequency and Short-Term Clinical Outcomes Among Individuals Receiving Maintenance Hemodialysis. Am J Hypertens. 2018 Feb 9;31(3):329-339.
Assimon MM, Flythe JE. Definitions of intradialytic hypotension. Semin Dial. 2017 Nov;30(6):464-472.
Assimon MM, Flythe JE. Thirty-Day Hospital Readmissions in the Hemodialysis Population: A Problem Well Put, But Half-Solved. Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1566-1568.
Assimon MM, Wenger JB, Wang L, Flythe JE. Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2016 Dec;68(6):911-922.
Assimon MM, Nguyen T, Katsanos SL, Brunelli SM, Flythe JE. Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study. BMC Nephrol. 2016 Nov 11;17(1):173.
Flythe JE, Assimon MM, Wenger JB, Wang L. Ultrafiltration Rates and the Quality Incentive Program: Proposed Measure Definitions and Their Potential Dialysis Facility Implications. Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1422-33.
Assimon MM, Flythe JE. Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base. Curr Opin Nephrol Hypertens. 2015 Nov;24(6):525-30.
Assimon MM, Flythe JE. Intradialytic Blood Pressure Abnormalities: The Highs, The Lows and All That Lies Between. Am J Nephrol. 2015;42(5):337-50.